Search Results - "McDermott, Matthew L."

Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma by Ferguson, L. Paige, Gatchalian, Jovylyn, McDermott, Matthew L., Nakamura, Mari, Chambers, Kendall, Rajbhandari, Nirakar, Lytle, Nikki K., Rosenthal, Sara Brin, Hamilton, Michael, Albini, Sonia, Wartenberg, Martin, Zlobec, Inti, Galván, José A., Karamitopoulou, Eva, Vavinskaya, Vera, Wascher, Alexis, Lowy, Andrew M., Schürch, Christian M., Puri, Pier Lorenzo, Bruneau, Benoit G., Hargreaves, Diana C., Reya, Tannishtha

“…Pancreatic cancer is characterized by extensive resistance to conventional therapies, making clinical management a challenge. Here we map the epigenetic…”
Get full text

Elevated Microparticle Tissue Factor Activity Differentiates Patients With Venous Thromboembolism in Anti-neutrophil Cytoplasmic Autoantibody Vasculitis by Mendoza, Carmen E., Brant, Elizabeth J., McDermott, Matthew L., Froment, Anne, Hu, Yichun, Hogan, Susan L., Jennette, J. Charles, Falk, Ronald J., Nachman, Patrick H., Derebail, Vimal K., Bunch, Donna O’Dell

“…Venous thromboembolism (VTE) is a life-threatening complication of anti-neutrophil cytoplasmic autoantibody (ANCA) vasculitis whose mechanism remains…”
Get full text

Abstract PO-043: Interception of pancreatic cancer progression by McDermott, Matthew L., Ferguson, Lesley P., Chambers, Kendall, Rajbhandari, Nirakar, Reya, Tannishtha

“…Pancreatic Cancer (PC) is projected to be one of the leading causes of cancer related death by 2030. Although other cancers have made significant strides…”
Get full text